✦ LIBER ✦

Carvedilol as a Potential Novel Disease Modifying Agent for the Treatment of Alzheimer's Disease

✍ Scribed by Pasinetti, Giulio; Rosen, Zohn; Rosenberg, Paul; Wang, Jun

Book ID: 123120255
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 106 KB
Volume: 5
Category: Article
ISSN: 1552-5260
DOI: 10.1016/j.jalz.2009.07.109

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cholinergic treatments with emphasis on

Cholinergic treatments with emphasis on M1 muscarinic agonists as potential disease-modifying agents for Alzheimer’s disease

✍ Abraham Fisher 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 113 KB

Development of a disease-modifying treat

Development of a disease-modifying treatment for Alzheimer’s disease: Alzhemed

✍ Paul S. Aisen 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Emerging prospects for the disease-modif

Emerging prospects for the disease-modifying treatment of Alzheimer's disease

✍ Lary C. Walker; Chris C. Ibegbu; Charles W. Todd; Harriet L. Robinson; Mathias J 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 351 KB

The Geminal Dimethyl Analogue of Flurbip

The Geminal Dimethyl Analogue of Flurbiprofen as a Novel Aβ42 Inhibitor and Potential Alzheimer′s Disease Modifying Agent.

✍ Nicholas Stock; et al. et al. 📂 Article 📅 2006 🏛 John Wiley and Sons ⚖ 15 KB

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.

M1 muscarinic agonists: Their potential

M1 muscarinic agonists: Their potential in treatment and as disease-modifying agents in Alzheimer's disease

✍ Abraham Fisher 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB 👁 1 views

Approaches Toward Development of a Disea

Approaches Toward Development of a Disease Modifying Treatment for Alzheimer's Disease

✍ Todd A. Verdoorn 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 10 KB